
INVIZYNE TECHNOLOGIES INC
IPONext Generation Biomanufacturing
Monrovia, United States · Founded 2019 · $2.0M raised
- Headquarters
- Monrovia, California
- Employees
- 11–50
- Founded
- 2019
- Business Model
- B2B
- Website
- invizyne.com
- Total Funding
- $2.0M
- Last Round
- $2.0M Grant
About
Invizyne Technologies (now rebranding as eXoZymes) is a cell-free biomanufacturing company that uses enzyme-based technology to produce fuels, foods, medicines, and specialty chemicals sustainably. The company's Cell-Free Biomanufacturing platform overcomes limitations of first-generation synthetic biology by liberating chemical manufacturing from biological cell constraints. Invizyne completed a Nasdaq IPO in November 2024 and has proven its platform in cannabinoids, biofuels, and terpene production.
Summary
INVIZYNE TECHNOLOGIES INC is a Biotech company based in Monrovia, United States, founded in 2019. It has raised $2.0M in total.
Tech & App Stack
2 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
No funding data available yet.
Know something? Help us improve our data.
Similar Companies
Leading North American energy infrastructure platform.
Green steel company using hydrogen and renewable electricity to decarbonize steel production. For...
Self-driving cars.
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Sustainable infrastructure finance